CARDIOVASCULAR SYSTEMS INC (CSII) Stock Overview
USA - NASDAQ:CSII - US1416191062 - Common Stock
CSII Key Statistics, Chart & Performance
The current stock price of CSII is 20 USD. In the past month the price increased by 0.81%. In the past year, price increased by 6.95%.
CSII Latest News, Press Relases and Analysis
CSII Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.42 | 220.78B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.47 | 195.91B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.27 | 149.82B | ||
| SYK | STRYKER CORP | 29.71 | 145.96B | ||
| MDT | MEDTRONIC PLC | 16.94 | 120.15B | ||
| BDX | BECTON DICKINSON AND CO | 13.02 | 53.26B | ||
| IDXX | IDEXX LABORATORIES INC | 53.36 | 51.27B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.61 | 44.68B | ||
| RMD | RESMED INC | 27.17 | 37.87B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.77 | 35.68B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.26 | 27.76B | ||
| DXCM | DEXCOM INC | 41.37 | 27.58B |
Related stock screener links
About CSII
Company Profile
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. The company is headquartered in St. Paul, Minnesota and currently employs 725 full-time employees. The company went IPO on 2006-06-28. The firm is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The firm has developed orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its peripheral artery disease (PAD) products are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.
Company Info
CARDIOVASCULAR SYSTEMS INC
1225 Old Hwy 8 Nw
ST. PAUL MINNESOTA 55112 US
CEO: Scott R. Ward
Employees: 725
Phone: 16512591600.0
CARDIOVASCULAR SYSTEMS INC / CSII FAQ
What does CSII do?
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. The company is headquartered in St. Paul, Minnesota and currently employs 725 full-time employees. The company went IPO on 2006-06-28. The firm is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The firm has developed orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its peripheral artery disease (PAD) products are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.
What is the stock price of CARDIOVASCULAR SYSTEMS INC today?
The current stock price of CSII is 20 USD. The price increased by 0.15% in the last trading session.
Does CSII stock pay dividends?
CSII does not pay a dividend.
How is the ChartMill rating for CARDIOVASCULAR SYSTEMS INC?
CSII has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is CSII stock listed?
CSII stock is listed on the Nasdaq exchange.
How is the market expecting CSII stock to perform?
12 analysts have analysed CSII and the average price target is 17.75 USD. This implies a price decrease of -11.26% is expected in the next year compared to the current price of 20.
What is the next earnings date for CSII stock?
CARDIOVASCULAR SYSTEMS INC (CSII) will report earnings on 2023-07-31, after the market close.
CSII Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CSII. When comparing the yearly performance of all stocks, CSII is one of the better performing stocks in the market, outperforming 94.88% of all stocks.
CSII Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CSII. CSII scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CSII Financial Highlights
Over the last trailing twelve months CSII reported a non-GAAP Earnings per Share(EPS) of -0.97. The EPS decreased by -46.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.08 |
CSII Forecast & Estimates
12 analysts have analysed CSII and the average price target is 17.75 USD. This implies a price decrease of -11.26% is expected in the next year compared to the current price of 20.
For the next year, analysts expect an EPS growth of 28.21% and a revenue growth 8.64% for CSII